Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-086128
Filing Date
2025-06-13
Accepted
2025-06-13 16:02:48
Documents
19
Effectiveness Date
2025-06-13

Document Format Files

Seq Description Document Type Size
1 S-8 sldb-20250613.htm S-8 103376
2 EX-4.1 sldb-ex4_1.htm EX-4.1 156775
3 EX-5.1 sldb-ex5_1.htm EX-5.1 17064
4 EX-23.1 sldb-ex23_1.htm EX-23.1 3685
5 EX-99.1 sldb-ex99_1.htm EX-99.1 151454
6 EX-FILING FEES sldb_exfilingfees.htm   iXBRL EX-FILING FEES 34696
7 GRAPHIC img14594897_0.jpg GRAPHIC 1899
8 GRAPHIC img14594897_1.jpg GRAPHIC 266724
9 GRAPHIC img14594897_2.jpg GRAPHIC 266724
  Complete submission text file 0000950170-25-086128.txt   1328431

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT sldb_exfilingfees_htm.xml XML 7469
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288022 | Film No.: 251046357
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)